Billiontoone, Inc. (NASDAQ:BLLN) Stock Has Consensus Price Target of $125.88

Shares of Billiontoone, Inc. (NASDAQ:BLLN) have earned a consensus rating of “Hold” from the eleven research firms that are covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a sell recommendation, two have given a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $125.88.

BLLN has been the topic of several research analyst reports. Canaccord Genuity Group initiated coverage on Billiontoone in a research report on Wednesday, September 2nd. They issued a “buy” rating and a $120.00 price objective on the stock. Wall Street Zen downgraded Billiontoone from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. JPMorgan Chase & Co. reduced their price objective on shares of Billiontoone from $145.00 to $130.00 and set an “overweight” rating on the stock in a research report on Thursday, August 6th. BTIG Research cut their target price on shares of Billiontoone from $142.00 to $130.00 and set a “buy” rating for the company in a research note on Thursday, August 6th. Finally, Zacks Research cut shares of Billiontoone from a “hold” rating to a “strong sell” rating in a research note on Monday, August 31st.

Billiontoone Trading Down 2.9%

Shares of BLLN stock opened at $118.18 on Friday. The firm’s 50 day moving average is $108.37 and its 200 day moving average is $99.23. The stock has a market capitalization of $5.58 billion and a P/E ratio of 168.83. The company has a current ratio of 11.69, a quick ratio of 11.31 and a debt-to-equity ratio of 0.17. Billiontoone has a 12-month low of $61.96 and a 12-month high of $150.44.

Billiontoone (NASDAQ:BLLN) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $0.15 EPS for the quarter, meeting analysts’ consensus estimates of $0.15. The company had revenue of $109.45 million during the quarter. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%. Research analysts expect that Billiontoone will post 0.83 earnings per share for the current year.

Insider Activity at Billiontoone

In other Billiontoone news, CTO David Tsao sold 20,000 shares of Billiontoone stock in a transaction that occurred on Wednesday, September 9th. The stock was sold at an average price of $98.77, for a total value of $1,975,400.00. Following the sale, the chief technology officer owned 1,000 shares of the company’s stock, valued at $98,770. The trade was a 95.24% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Thomas Lynch sold 35,112 shares of the stock in a transaction that occurred on Thursday, September 17th. The shares were sold at an average price of $110.33, for a total value of $3,873,906.96. Following the transaction, the insider owned 700 shares of the company’s stock, valued at $77,231. This represents a 98.05% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 244,108 shares of company stock valued at $27,991,574. Insiders own 50.22% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in BLLN. Integrated Wealth Concepts LLC bought a new stake in Billiontoone during the second quarter worth approximately $29,000. MCF Advisors LLC increased its position in shares of Billiontoone by 330.8% during the 2nd quarter. MCF Advisors LLC now owns 448 shares of the company’s stock valued at $54,000 after purchasing an additional 344 shares during the last quarter. Thrive Wealth Management LLC purchased a new stake in Billiontoone during the 2nd quarter valued at $240,000. Caitong International Asset Management Co. Ltd purchased a new position in Billiontoone during the fourth quarter worth $230,000. Finally, Jasper Ridge Partners L.P. purchased a new stake in shares of Billiontoone in the second quarter valued at $615,000.

About Billiontoone

BillionToOne, Inc is a molecular diagnostics company that develops blood-based tests designed to provide genetic and health information from small amounts of biological material. The company’s technology uses its proprietary quantitative counting template approach to improve the accuracy and sensitivity of molecular testing.

The company’s primary offerings include UNITY, a portfolio of prenatal genetic tests. These services support screening for chromosomal conditions, single-gene disorders and carrier status, and are designed to help healthcare providers assess fetal and maternal genetic risks using a maternal blood sample.